Detection of AML1/ETO Fusion Transcripts in Patients With t(8; 21) Acute Myeloid Leukemia After Allogeneic Bone Marrow Transplantation or Peripheral Blood Progenitor Cell Transplantation-Reference-Cited by-同舟云学术

Detection of AML1/ETO Fusion Transcripts in Patients With t(8; 21) Acute Myeloid Leukemia After Allogeneic Bone Marrow Transplantation or Peripheral Blood Progenitor Cell Transplantation

Published:1997-10-15 Issue:8 Volume:90 Page:3230-3231
ISSN:1528-0020
Container-title:Blood
language:en
Short-container-title:

Author:

Elmaagacli Ahmet H.¹,Beelen Dietrich W.¹,Stockova Jitka¹,Trzensky Susanne¹,Kroll Melanie¹,Schaefer Ulrich W.¹,Stein Christina²,Opalka Bertram³

Affiliation:

1. Department of Bone Marrow Transplantation

2. Department of Forensic Medicine

3. Department of Internal Medicine (Tumor Research) University Hospital of Essen Essen, Germany

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/90/8/3230/1415908/3230.pdf

Reference8 articles.

1. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8; 21)(q22; q22) translocation.;Downing;Blood,1993

2. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8; 21) leukemia.;Jurlander;Blood,1996

3. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8; 21) acute myelogenous leukemia.;Miyamoto;Blood,1996

4. Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8; 21) in long-term remission.;Satake;Br J Haematol,1995

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO–positive acute myeloid leukemia;Frontiers in Pharmacology;2023-01-13

2. Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse;British Journal of Haematology;2021-04-13

3. Molecular Methods Used for Detection of Minimal Residual Disease Following Hematopoietic Stem Cell Transplantation in Myeloid Disorders;Methods in Molecular Biology;2013-12-27

4. Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22);International Journal of Hematology;2013-04-24

5. Minimal Residual Disease;Allogeneic Stem Cell Transplantation;2009-11-27